Mirae Asset Global Investments Co., Ltd. Bio N Tech Se Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,513 shares of BNTX stock, worth $413,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,513
Previous 3,931
10.63%
Holding current value
$413,163
Previous $466,000
14.16%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.22MShares$967 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$531 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$518 Million2.03% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$213 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...